HSBC has provided Independence Products Ltd (‘IPL’) with financing that supports the company’s exciting growth journey and ambitions. IPL is a leading supplier of prescribed infection prevention products, primarily to patients with renal conditions for use outside the hospital setting.
Since investing in IPL in 2023, we have continued to support expansion of the company’s product set and exposure to larger patient populations, organically and through acquisition.
